Quad Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 24-06-2024
- Paid Up Capital ₹ 12.43 Cr
as on 24-06-2024
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 35.67 Cr
as on 24-06-2024
- Satisfied Charges ₹ 11.83 Cr
as on 24-06-2024
- Revenue -15.20%
(FY 2023)
- Profit -9.54%
(FY 2023)
- Ebitda 96.84%
(FY 2023)
- Net Worth 24.46%
(FY 2023)
- Total Assets 13.46%
(FY 2023)
About Quad Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 12.43 Cr.
The company currently has active open charges totaling ₹35.67 Cr. The company has closed loans amounting to ₹11.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Quad Lifesciences Private Limited India is Samir Pruthi as CEO. Om Sharma and Meera Pruthi serve as directors at the Company.
- CIN/LLPIN
U24232PB2012PTC038263
- Company No.
038263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2012
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Quad Lifesciences Private Limited offer?
Quad Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Plant Extracts, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic Powder and Medicinal Herbs, Medicinal Plant, Fruit Extracts.
Who are the key members and board of directors at Quad Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samir Pruthi | CEO | 01-Apr-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Om Sharma  | Director | 05-Feb-2014 | Current |
| Meera Pruthi | Director | 01-Oct-2012 | Current |
Financial Performance and Corporate Structure Insights of Quad Lifesciences.
Quad Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.2% decrease. The company also saw a slight decrease in profitability, with a 9.54% decrease in profit. The company's net worth Soared by an impressive increase of 24.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quad Lifesciences?
In 2022, Quad Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Nov 2021 | ₹1.29 Cr | Open |
Yes Bank Limited Creation Date: 20 Nov 2017 | ₹11.00 Cr | Open |
Canara Bank Creation Date: 18 Sep 2013 | ₹23.38 Cr | Open |
How Many Employees Work at Quad Lifesciences?
Quad Lifesciences has a workforce of 125 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quad Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quad Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
